Duan Zhi-Liang, Liu Hui-Fang, Huang Xi, Wang Si-Na, Yang Jin-Lin, Chen Xin-Yu, Li De-Zhou, Zhong Xiao-Zhi, Chen Bo-Kun, Wen Jin-Sheng
Department of Microbiology and Immunology, Wenzhou Medical University, Wenzhou, China; Department of Clinical Laboratory, The Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China; Institute of Arboviruses, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, China.
Department of Microbiology and Immunology, Wenzhou Medical University, Wenzhou, China.
Virus Res. 2015 Jan 22;196:5-12. doi: 10.1016/j.virusres.2014.10.022. Epub 2014 Nov 1.
In this study, we set out to identify dengue virus serotype 2 (DENV-2)-specific HLA-A2402-restricted epitopes and determine the characteristics of T cells generated to these epitopes. We screened the full-length amino-acid sequence of DENV-2 to find potential epitopes using the SYFPEITHI algorithm. Twelve putative HLA-A2402-binding peptides conserved in hundreds of DENV-2 strains were synthesized, and the HLA restriction of peptides was tested in HLA-A2402 transgenic mice. Nine peptides (NS4b(228-237), NS2a(73-81), E(298-306), M(141-149), NS4a(96-105), NS4b(159-168), NS5(475-484), NS1(162-171), and NS5(611-620)) induced high levels of peptide-specific IFN-γ-secreting cells in HLA-A2402 transgenic mice. Apart from IFN-γ, NS4b(228-237-), NS2a(73-81-) and E(298-306)-specific CD8(+) cells produced TNF-α and IL-6 simultaneously, whereas M(141-149-) and NS5(475-484-) CD8(+) cells produced only IL-6. Moreover, splenic mononuclear cells (SMCs) efficiently recognized and killed peptide-pulsed splenocytes. Furthermore, each of nine peptides could be recognized by splenocytes from DENV-2-infected HLA-A2402 transgenic mice. The SMCs from HLA-A2402 transgenic mice immunized with nine immunogenic peptides efficiently killed DENV-2-infected splenic monocytes. The present identified epitopes have the potential to be new diagnostic tools for characterization of T-cell immunity in DENV infection and may serve as part of a universal epitope-based vaccine.
在本研究中,我们旨在鉴定登革病毒2型(DENV-2)特异性HLA-A2402限制性表位,并确定针对这些表位产生的T细胞的特征。我们使用SYFPEITHI算法筛选DENV-2的全长氨基酸序列以寻找潜在表位。合成了在数百株DENV-2菌株中保守的12种假定的HLA-A2402结合肽,并在HLA-A2402转基因小鼠中测试了肽的HLA限制性。9种肽(NS4b(228 - 237)、NS2a(73 - 81)、E(298 - 306)、M(141 - 149)、NS4a(96 - 105)、NS4b(159 - 168)、NS5(475 - 484)、NS1(162 - 171)和NS5(611 - 620))在HLA-A2402转基因小鼠中诱导了高水平的肽特异性干扰素-γ分泌细胞。除了干扰素-γ外,NS4b(228 - 237)、NS2a(73 - 81)和E(298 - 306)特异性CD8(+)细胞同时产生肿瘤坏死因子-α和白细胞介素-6,而M(141 - 149)和NS5(475 - 484) CD8(+)细胞仅产生白细胞介素-6。此外,脾单核细胞(SMC)有效识别并杀死肽脉冲的脾细胞。此外,9种肽中的每一种都能被DENV-2感染的HLA-A2402转基因小鼠的脾细胞识别。用9种免疫原性肽免疫的HLA-A2402转基因小鼠的SMC有效杀死了DENV-2感染的脾单核细胞。目前鉴定出的表位有可能成为用于表征登革病毒感染中T细胞免疫的新诊断工具,并可能作为基于通用表位的疫苗的一部分。